157 related articles for article (PubMed ID: 26688135)
1. Simplification of the Fuhrman grading system for renal cell carcinoma.
Smith ZL; Pietzak EJ; Meise CK; Van Arsdalen K; Wein AJ; Malkowicz SB; Guzzo TJ
Can J Urol; 2015 Dec; 22(6):8069-73. PubMed ID: 26688135
[TBL] [Abstract][Full Text] [Related]
2. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
[TBL] [Abstract][Full Text] [Related]
3. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of new schemes to group Fuhrman grades in clinical practice for clear cell renal tumour].
Morán E; Rogel R; Soto A; Ruiz-Cerdá JL; Budía A; Salom JV; Jiménez-Cruz JF
Actas Urol Esp; 2012 Jun; 36(6):352-8. PubMed ID: 22266258
[TBL] [Abstract][Full Text] [Related]
5. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
6. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
[TBL] [Abstract][Full Text] [Related]
7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
8. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
[TBL] [Abstract][Full Text] [Related]
9. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
10. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
[TBL] [Abstract][Full Text] [Related]
11. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
[TBL] [Abstract][Full Text] [Related]
13. Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.
Zhang ZL; Chen W; Li YH; Liu ZW; Luo JH; Lau W; Tan MH; Zhou FJ
Chin J Cancer; 2011 Nov; 30(11):772-8. PubMed ID: 22035858
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma.
Liu W; Liu H; Liu Y; Xu L; Zhang W; Zhu Y; Xu J; Gu J
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S575-83. PubMed ID: 24715215
[TBL] [Abstract][Full Text] [Related]
15. Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.
Chen SH; Xu LY; Wu YP; Ke ZB; Huang P; Lin F; Li XD; Xue XY; Wei Y; Zheng QS; Xu N
BMC Cancer; 2021 Jan; 21(1):79. PubMed ID: 33468079
[TBL] [Abstract][Full Text] [Related]
16. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.
Chen L; Ma X; Li H; Gu L; Li X; Gao Y; Xie Y; Zhang X
PLoS One; 2017; 12(3):e0173953. PubMed ID: 28288191
[TBL] [Abstract][Full Text] [Related]
17. Prognostic ability of simplified nuclear grading of renal cell carcinoma.
Rioux-Leclercq N; Karakiewicz PI; Trinh QD; Ficarra V; Cindolo L; de la Taille A; Tostain J; Zigeuner R; Mejean A; Patard JJ
Cancer; 2007 Mar; 109(5):868-74. PubMed ID: 17262800
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
[TBL] [Abstract][Full Text] [Related]
19. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
[TBL] [Abstract][Full Text] [Related]
20. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
